Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators Results from the Triggers of Ventricular Arrhythmias (TOVA) study by Whang, William et al.
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OBJECTIVES We sought to examine the relationship between symptoms of depression and shock-treated
ventricular arrhythmias among implantable cardioverter-defibrillator (ICD) patients.
BACKGROUND Depression predicts mortality in patients with coronary artery disease (CAD), but whether
this is via an increased risk of fatal ventricular arrhythmias is unclear.
METHODS We prospectively analyzed data on symptoms of depression and risk of ventricular arrhythmia
(ventricular tachycardia/ventricular fibrillation [VT/VF]) resulting in ICD discharge in the
Triggers of Ventricular Arrhythmias (TOVA) study. Symptoms were assessed by the Center
for Epidemiologic Studies-Depression (CES-D) scale. Scores of 16 to 26 and 27
represented mild and moderate/severe depression, respectively. The Cox and Anderson-Gill
proportional hazards models were used to test for associations among all patients and patients
with CAD.
RESULTS Among 645 patients with baseline assessments, 90 (14%) were mildly depressed and 25
(3.9%) were moderately to severely depressed. Moderate/severe depression was associated
with time to first shock for VT/VF (hazard ratio [HR] 3.2, 95% confidence interval [CI] 1.1
to 9.9) and all shocks for VT/VF including recurrent episodes (HR 3.2, 95% CI 1.2 to 8.6).
Among the 476 CAD patients, the association with time to first shock (HR 6.4, 95% CI 1.9
to 21.1) and all shocks (HR 8.3, 95% CI 2.9 to 23.3) remained. The risk of shock for VT/VF
was associated with depression severity in the total population (p for trend 0.02) and among
patients with CAD (p  0.01), even after controlling for multiple confounders.
CONCLUSIONS More severe symptoms of depression predict shocks for VT/VF among ICD patients. The
elevated risk of VT/VF among patients with CAD and depression suggests that arrhythmia
may contribute significantly to total mortality in this subgroup. (J Am Coll Cardiol 2005;
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.12.05345:1090–5) © 2005 by the American College of Cardiology Foundation
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oepression has been identified as a risk factor for the
evelopment of cardiovascular disease and for recurrent
ardiac events and mortality among those with established
oronary artery disease (CAD) (1,2). A number of studies
ave suggested that the poor cardiac prognosis associated
ith depression may be due to an arrhythmic mechanism
3,4), especially among patients with CAD (5–9). Among
atients with implantable cardioverter-defibrillators (ICDs),
ho are at high risk for ventricular arrhythmias, there have
een relatively few studies of depression as a predictor of
rrhythmic outcomes (10,11).
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y funding from the National Heart, Lung, and Blood Institute (HL041016);
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Manuscript received September 1, 2004; revised manuscript received November 22,
004, accepted December 14, 2004.We sought to determine whether depression was associ-
ted with an increased risk of shock-treated malignant
entricular arrhythmia in a large, prospectively collected
ample of ICD patients. In addition, we sought to gain
nsight into the mode by which depression worsens prog-
osis among patients with CAD by analyzing the subgroup
f patients with CAD separately.
ETHODS
tudy design. The Triggers of Ventricular Arrhythmias
TOVA) study has been described previously (12). Briefly, it
s a prospective cohort study of ICD patients conducted at
1 centers in the United States and designed to identify
riggers of ventricular tachycardia/ventricular fibrillation
VT/VF). Patients met class I to IIb indications for ICD
mplant according to the 1998 American College of Cardi-
logy/American Heart Association guidelines (13). Enroll-
ent began in June 2000, and patients were identified at the
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April 5, 2005:1090–5 Depression and ICD Shocksime of implant or through the ICD clinics in participating
nstitutions.
epression symptom assessment. At entry into the study,
nformation was collected on baseline clinical characteristics
nd information on symptoms of depression was collected
n a subset of the patients. Of the 1,188 patients partici-
ating in TOVA, the last 645 patients enrolled were asked
o complete the Centers for Epidemiologic Studies-
epression (CES-D) scale (14). The CES-D scale is a
0-item survey that measures mood, somatic symptoms,
ocial interactions, and motor functioning according to a
-point Likert scale. The survey asks about the frequency in
he past week that one has felt or behaved a certain way.
tems include: “I felt depressed,” “My sleep was restless,” “I
ost interest in my usual activities,” “I felt like I was moving
oo slowly,” and “I did not like eating; my appetite was
oor.” The CES-D scale score is a sum total over the 20
tems and can range from 0 to 60, with higher scores
ndicating more severe symptoms of depression. The
ES-D scale has been shown to have high internal consis-
ency (Cronbach’s alpha 0.85 in the general population) and
atisfactory test-retest reliability over several weeks’ time
14–16). For this analysis, we categorized patients with
cores of 16 to 26 as mildly depressed (17) and those with
cores of 27 or greater as moderately to severely depressed.
he cutoff of 27 or greater has been shown to detect clinical
epression with a specificity of 70% among medical patients
18).
Patients were asked to call the study and clinical staff at
articipating institutions within 72 h of an ICD discharge.
ll of the devices in the study had electrogram storage
apability, and reported device discharges were evaluated by
n electrophysiologist (P.J.W., C.M.A., J.P.S.) at the cen-
ral core laboratory to identify episodes of sustained VT or
F. The primary end point in this analysis was first
ost-enrollment shock for VT or VF. A secondary end
oint was two or more appropriate ICD shocks within a
4-h period (19,20).
tatistical analysis. Means or proportions for baseline
linical variables were calculated according to the severity of
epression. Chi-square tests were used to compare categoric
ariables. Visual inspection of histograms as well as skew-
ess and kurtosis statistics were used to assess continuous
ariables for normality, and analysis of variance or non-
arametric tests were used to compare continuous variables
Abbreviations and Acronyms
ACE  angiotensin-converting enzyme
ARB  angiotensin receptor blocker
CES-D  Centers for Epidemiologic Studies-Depression
HRV  heart rate variability
ICD  implantable cardioverter-defibrillator
SSRI  selective serotonin reuptake inhibitor
VT/VF  ventricular tachycardia/ventricular fibrillationy depression category. Cumulative event proportions were nalculated by the Kaplan-Meier method, and outcome
ifferences of patients with depression versus those without
ere assessed with the log-rank test.
Cox proportional hazards models were used to evaluate
ssociations between depression severity at enrollment and
ime to first ICD discharge for a confirmed episode of
T/VF. The proportional hazards assumption was tested
ith appropriate time interaction variables. In addition,
nderson-Gill proportional hazards models were used in
rder to incorporate recurrent ICD discharges in our anal-
sis (21). All of the covariates included in the multivariable
odels varied significantly according to depression category
r resulted in a change of 10% in the coefficient for either
epression group in a model that already included age and
ender. The relationship between depression severity and
CD discharge was assessed with a linear trend variable that
ssumed three possible values for no symptoms of depres-
ion, mild, or moderate-to-severe symptoms. The interac-
ion between CAD and depression category was tested with
ultiplicative indicator variables among all patients, and
ultivariable proportional hazards analyses were performed
n the subgroup of patients with a history of CAD at
aseline. In a secondary analysis, we modeled the time to
rst episode of 2 or more appropriate ICD shocks within a
4-h time period using Cox proportional hazards models.
ll p values are two-tailed and all confidence intervals (CIs)
omputed at the 95% level (SAS Version 8.2, SAS, Cary,
orth Carolina).
ESULTS
aseline characteristics. Among 645 patients for whom
aseline CES-D scale scores were available, 90 patients
14%) were categorized as mildly depressed (CES-D scale
ore 16 to 26) and 25 (3.9%) were categorized as moderately
o severely depressed (CES-D 27). Depressed patients
ere younger and more often women compared with
atients without depression (Table 1). The median time
rom ICD implant to enrollment was 16.4 (interquartile
ange 6.7 to 35.2) months among patients without symp-
oms of depression, 21.4 (interquartile range 8.0 to 38.9)
onths among patients with mild symptoms, and 23.4
interquartile range 16.7 to 37) months among patients with
oderate to severe symptoms (p  0.36, Kruskal-Wallis
est). Alcohol use was less frequent among depressed pa-
ients. Several baseline characteristics, including history of
AD, angina, congestive heart failure, and prior ICD
ischarge, differed significantly between patient groups but
xhibited a non-linear relationship with CES-D scale score.
hese characteristics were more frequent in patients with
ild depression compared with those without depression,
ut less frequent in patients with moderate to severe
epression compared to those with mild depression. Selec-
ive serotonin reuptake inhibitor (SSRI) use was higher with
orsening severity of depression, and beta-blocker use was
ot significantly different between groups.
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Depression and ICD Shocks April 5, 2005:1090–5ES-D scale score and risk of shock for VT/VF. During
median follow-up of 359 days (interquartile range 180 to
26), 59 patients experienced a total of 103 appropriate
CD shocks. Kaplan-Meier curves of the time to appropri-
te ICD discharge stratified according to the presence of
epression (CES-D scale score 16) are shown in Figure 1
p 0.02, log rank test). A Cox proportional hazards model
hat contained baseline depression category and adjusted for
ge and gender revealed positive relationships between both
ategories of depression and ICD discharges for VT or VF
Table 2). In a multivariable Cox proportional hazards
odel that adjusted for age, gender, number of prior ICD
ischarges (0, 1, 2 to 4, 5 or more), time from ICD implant
o study enrollment, cardiac arrest as a device indication,
AD, angina class, congestive heart failure class, left
entricular ejection fraction, smoking, alcohol use, SSRI
se, and use of angiotensin-converting enzyme (ACE)
nhibitors or angiotensin receptor blocker (ARBs), moder-
te to severe depression (CES-D scale score 27) was
ssociated with a statistically significant increased risk of
Table 1. Baseline Characteristics Among Patie
No
Depressi
(n  53
Mean age (yrs) 64.6  1
Women (%) 16.4
White (%) 90.4
 High school education (%) 85.8
Cardiac arrest as indication for device
implantation (%)
27.1
Monomorphic VT at EPS (%) 32.8
ICD implant 6 months before
enrollment (%)
77.4
Prior ICD discharge (%) 10.6
Hypertension (%) 55.5
Diabetes (%) 21.9
Past/current smoking (%) 71.8
Alcohol use (%) 60.0
Coffee use (%) 59.3
Body mass index 30 kg/m2 (%) 30.4
Coronary artery disease (%) 73.7
Angina (%) 7.9
Previous CABG surgery (%) 41.5
CHF 47.2
LVEF (%)
0.20 11.7
0.20 to 0.34 41.5
0.35 46.9
Amiodarone (%) 22.5
Digoxin (%) 34.3
Diuretics (%) 46.4
ACE inhibitors/ARBs (%) 41.5
Beta-blocker (%) 67.1
SSRI (%) 2.6
TCA (%) 0.8
*Analysis of variance; all other p values according to likeliho
ACE  angiotensin-converting enzyme; ARB  angiot
CHF  congestive heart failure; EPS  electrophysiology s
ventricular ejection fraction; SSRI  selective serotonin reup
tachycardia.ppropriate ICD shocks (hazard ratio [HR] 3.2, 95% CI 1.1 qo 9.9). The Andersen-Gill model, which included recur-
ent shocks in the dependent variable and which adjusted
or the same covariates as the Cox model, also indicated an
ncreased risk of shocks for patients with moderate to severe
epression (hazard ratio 3.2, 95% CI 1.2 to 8.6). A test for
rend was statistically significant for both the Cox and
nderson-Gill models (p  0.02), indicating that higher
evels of depressive symptoms were associated with a higher
isk of appropriate shock.
AD subgroup. Among the subgroup of patients with
AD, there was a strong positive relationship between
oderate to severe depression and appropriate shocks (Ta-
le 3). In the Cox and Anderson-Gill multivariable propor-
ional hazards models, depression scores 27 conferred
azard ratios of 6.4 (95% CI 1.9 to 21.1) and 8.3 (95% CI
.9 to 23.3), respectively. In models that included all
atients, tests for an interaction between CAD and depres-
ion score were statistically significant for Anderson-Gill
odels (p  0.04), but not for Cox models (p  0.16),
lthough our statistical power to examine this issue was
y Depression Category
Mild
Depression
(n  90)
Moderate-Severe
Depression
(n  25) p Value
62.7  13.6 58.8  13.3 0.04*
26.7 28.0 0.03
87.8 80.0 0.21
81.8 84.0 0.61
25.0 20.0 0.69
33.3 32.0 0.99
77.8 80.0 0.95
20.0 12.0 0.04
64.4 68.0 0.15
25.6 24.0 0.73
72.2 68.0 0.91
47.8 48.0 0.06
63.3 60.0 0.77
34.4 28.0 0.71
83.3 60.0 0.04
23.3 12.0 0.001
43.3 24.0 0.20
62.2 52.0 0.03
0.93
13.3 12.5
44.6 37.5
42.2 50.0
25.6 12.0 0.36
36.7 44.0 0.58
54.4 52.0 0.34
46.7 52.0 0.41
67.8 62.5 0.88
7.8 16.0 0.001
1.1 0.0 0.85
io chi-square tests.
I receptor blocker; CABG  coronary artery bypass graft;
CD  implantable cardioverter-defibrillator; LVEF  left
nhibitor; TCA  tricyclic antidepressant; VT  ventricularnts b
on
0)
2.3
od rat
ensin I
tudy; Iuite limited.
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April 5, 2005:1090–5 Depression and ICD Shocksecondary/sensitivity analyses. In a secondary analysis of
wo or more appropriate ICD shocks within a 24-h time
eriod, moderate to severe depression was associated with
n elevated risk of such episodes in multivariable analyses,
espite only 16 events (Table 4). We also estimated Cox
roportional hazards models after removal of those who had
ad ICD discharges before study enrollment. The HR for
oderate to severe depression was similar to our main
nalysis (HR 3.7, 95% CI 1.2 to 11.6), with a significant test
or trend across categories (p  0.04). Finally, a post-hoc
ox regression analysis suggested that the relationship
etween depression category and risk of shock was stronger
mong patients with ICD implant 6 months before
nrollment (p for interaction  0.09).
ISCUSSION
n this prospective multicenter study, symptoms of depres-
ion significantly predicted appropriate ICD shocks, even
ith adjustment for other important comorbidities, medi-
ations, and history of prior shocks. Few prior studies have
valuated the long-term risk conferred by depression in
CD patients. Dunbar et al. (10) studied 172 patients with
ewly implanted ICDs through a survey that described 6
ood states including depression-dejection and tension-
nxiety, and found that 1-month total mood disturbance
core predicted shock or anti-tachycardia pacing at 3
onths. Hermann et al. (11) assessed 105 patients before
igure 1. Time to first appropriate implantable cardioverter-defibrillator
ICD) discharge by presence of depression according to Centers for Epide-
iologic Studies-Depression scale score 16 (p  0.02, log-rank test).
able 2. Proportional Hazards Models of Time to First Appropr
CD Discharge (Anderson-Gill Model), All Patients
Depression Severity
Cox Proportional Hazards Model*
(n  645, s  59)
Co
Hazard Ratio (95% CI) p Value Haz
ild 1.9 (1.0–3.5) 0.05
oderate to severe 2.7 (0.97–7.8) 0.06
p for trend 0.01
Adjusted for age and gender. ‘n’ indicates number of observations, ‘s’ indicates numb
0, 1, 2 to 4, 5 or more), time from ICD implant to study enrollment, cardiac arrest
lcohol use, SSRI use, and use of ACE inhibitors or ARBs.
CI  confidence interval; other abbreviations as in Table 1.CD implantation with the Hospital Anxiety and Depres-
ion Scale. The odds of VT at one year were significantly
igher among those with abnormal depression scores in
ultivariable analyses. Our analysis provides further pro-
pective evidence for the long-term association between
epression and ventricular arrhythmias in ICD patients and
s strengthened by the size of the TOVA study sample and
y the involvement of patients from multiple centers in the
.S.
In our study, depression conferred an elevated risk for
CD shocks among the subgroup of patients with a history
f CAD. Previous studies have shown that depressed
ost-myocardial infarction patients have higher risks for
ortality (2,9), mortality or cardiac arrest (6), and sudden
eath or sustained VT (7). Our analysis is also consistent
ith the study by Carney et al. (8) in which depression was
ssociated with VT episodes detected by 24-h Holter
onitoring among patients with CAD, even after adjust-
ent for differences in beta-blocker use. In the context of
hese previous investigations, our results indicate that an
rrhythmic mechanism may account for a significant part of
he elevated mortality risk associated with depression among
atients with CAD.
Although our analysis indicates that depression may
redict the development of malignant ventricular arrhyth-
ias, to determine whether depression is causative will
equire confirmatory studies, as well as studies of the
echanism of the arrhythmic risk. Reduced heart rate
ariability (HRV) is more common among depressed pa-
ients after acute myocardial infarction (22). A rodent model
f depression, manifested as anhedonia in response to
hronic mild stress, has revealed decreased HRV and shorter
ime to onset of ventricular arrhythmias in response to
conitine infusion (23). Depression has also been associated
ith reductions in red blood cell levels of omega-3 fatty
cids (24), which are related to the risk of sudden death
25,26). In addition, depression has been linked to higher
evels of platelet activation (27) and to enhanced activity of
he clotting cascade (28).
Possible interventions to reduce the arrhythmic risk
ssociated with depression could involve numerous ap-
roaches, from treatment of the “upstream” mood disorder
CD Discharge (Cox Model) and Time to Any Appropriate
portional Hazards Model†
(n  619, s  58)
Anderson-Gill Proportional
Hazards Model†
(n  662, s  102)
atio (95% CI) p Value Hazard Ratio (95% CI) p Value
(0.86–3.5) 0.12 1.7 (1.0–2.9) 0.05
(1.1–9.9) 0.04 3.2 (1.2–8.6) 0.02
p for trend 0.02 p for trend 0.01
ppropriate ICD shocks. †Adjusted for age, gender, number of prior ICD discharges
evice indication, coronary artery disease, angina class, CHF class, LVEF, smoking,iate I
x Pro
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Depression and ICD Shocks April 5, 2005:1090–5o stabilization with anti-arrhythmic therapy. Treatment of
atients with psychotropic medications has shown mixed
esults. An uncontrolled pilot study of paroxetine in the
reatment of five ICD patients with panic disorder, agora-
hobia, and depression found that the rate of ectopy and
CD therapies decreased after six months of treatment (29).
he Sertraline Antidepressant Heart Attack Randomized
rial study did not detect a significant difference in ventric-
lar arrhythmias by 24-h Holter monitor among 369
atients with acute coronary syndrome and depression
andomized to sertraline or placebo, although the study was
ot powered for this outcome (30). An analysis of the
anadian Amiodarone Myocardial Infarction Arrhythmia
rial found that symptoms of depression were associated
ith sudden cardiac death among placebo-treated patients
ut not among amiodarone-treated patients, suggesting a
ossible protective effect from amiodarone (5). Understand-
ng of the underlying pathways linking depression and
rrhythmia may further guide the search for an effective
reatment.
Our finding that episodes of two or more appropriate
hocks within a 24-h period were more common among
epressed patients raises possible implications for device
herapy. A number of studies have shown that shocks
orsen symptoms of depression and psychologic well-being
n ICD patients (31–34). Therefore, depression may in-
rease the susceptibility to ventricular arrhythmias that
equire ICD shocks, which in turn worsen depressive
ymptoms and lead to further malignant arrhythmias. If this
ere the case, anti-tachycardia pacing could interrupt this
ycle by reducing the frequency of shocks. Recent data from
he PainFREE Rx II Trial that support the use of anti-
achycardia pacing for fast VT events may be particularly
elevant for shock prevention in depressed patients.
Finally, it is notable that about 18% of the patients in our
ample were classified as mildly to severely depressed ac-
ording to their CES-D score, a prevalence estimate that
orresponds to other cardiovascular disease samples, yet only
bout 10% of these patients were treated with SSRIs.
lthough our estimate of the use of SSRIs may be subject to
nderreporting, it is likely that depression was undertreated
n our sample. The relatively low number of ICD patients
able 3. Proportional Hazards Models of Time to First Appropr
CD Discharge (Anderson-Gill Model) Among Patients With C
Depression Severity
Cox Proportional Hazards Model*
(n  476, s  46)
Co
Hazard Ratio (95% CI) p Value Haz
ild 1.8 (0.91–3.7) 0.09
oderate to severe 4.5 (1.5–13.0) 0.006
p for trend 0.004
Adjusted for age and gender. ‘n’ indicates number of observations, ‘s’ indicates numb
0, 1, 2 to 4, 5 or more), time from ICD implant to study enrollment, cardiac arrest a
se of ACE inhibitors or ARBs.
CAD  coronary artery disease; other abbreviations as in Tables 1 and 2.hat received pharmacologic treatment for depression sug-
aests that increased surveillance for depression in ICD
atients may be needed. Primary care studies have suggested
hat inquiring about depressed mood and anhedonia have
uitable sensitivity and specificity for detecting depression in
edical settings (35). More aggressive surveillance and
reatment of mood disorders with one or both of an SSRI
nd counseling may significantly affect the quality of life of
CD patients (36).
tudy limitations. There are several limitations to our
tudy. We did not assess symptoms of depression in the
ntire TOVA study cohort, because the CES-D scale was
ntroduced to the study after enrollment had already begun.
lthough this limits the power of our study, we were able to
etect significant relationships between appropriate ICD
hocks and symptoms of depression in multivariable analy-
es. In addition, we used symptoms of depression assessed at
aseline for our analysis; thus, we cannot evaluate whether
hanges in symptoms, which may have additional prognos-
ic information (37), alter the risk of ICD shocks for
T/VF. Also, although we attempted to adjust for as many
otential confounding factors as possible in our multivari-
ble analyses, there may be unmeasured confounders that
xplain the relationship between depression and shocks in
ur analysis.
onclusions. In summary, we found that symptoms of
epression are predictive of shock-treated ventricular ar-
hythmias among a sample of ICD patients. These data
upport ventricular arrhythmia as a potential mechanism for
he elevated mortality risk among depressed patients with
CD Discharge (Cox Model) and Time to Any Appropriate
portional Hazards Model†
(n  465, s  46)
Anderson-Gill Proportional
Hazards Model†
(n  501, s  82)
atio (95% CI) p Value Hazard Ratio (95% CI) p Value
(0.72–3.5) 0.25 1.6 (0.88–3.0) 0.12
(1.9–21.1) 0.002 8.3 (2.9–23.3) 0.001
p for trend 0.006 p for trend 0.001
ppropriate ICD shocks. †Adjusted for age, gender, number of prior ICD discharges
ice indication, angina class, CHF class, LVEF, smoking, alcohol use, SSRI use, and
able 4. Multivariable Proportional Hazards Model of Time to
irst Episode of 2 or More Appropriate ICD Discharges
ithin 24 Hours (Cox Model), All Patients*
Depression Severity
Cox Proportional Hazards Model
(n  619, s  16)
Hazard Ratio (95% CI) p Value
ild 4.1 (1.1–14.9) 0.03
oderate to severe 6.4 (1.1–36.4) 0.04
p for trend 0.008
Adjusted for age, gender, number of prior ICD discharges (0, 1, 2 to 4, 5 or more),
ime from ICD implant to study enrollment, cardiac arrest as a device indication,
AD, angina class, CHF class, LVEF, smoking, alcohol use, SSRI use, and use of
CE inhibitors or ARBs. ‘n’ indicates number of observations, ‘s’ indicates number ofiate I
AD
x Pro
ard R
1.6
6.4
er of a
s a devppropriate ICD shock.
Abbreviations as in Tables 1 to 3.
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